Guoxiang Cai

1.8k total citations
60 papers, 1.3k citations indexed

About

Guoxiang Cai is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Guoxiang Cai has authored 60 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Oncology, 32 papers in Surgery and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Guoxiang Cai's work include Colorectal Cancer Surgical Treatments (31 papers), Colorectal and Anal Carcinomas (27 papers) and Colorectal Cancer Screening and Detection (18 papers). Guoxiang Cai is often cited by papers focused on Colorectal Cancer Surgical Treatments (31 papers), Colorectal and Anal Carcinomas (27 papers) and Colorectal Cancer Screening and Detection (18 papers). Guoxiang Cai collaborates with scholars based in China, United States and Italy. Guoxiang Cai's co-authors include Sanjun Cai, Yanlei Ma, Yongzhi Yang, Sanjun Cai, Weixing Dai, Ye Xu, Qingguo Li, Shaobo Mo, S. Zhang and Wenhao Weng and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Guoxiang Cai

60 papers receiving 1.3k citations

Peers

Guoxiang Cai

ONCOL

SURGE

PRM

Yasutaka Sukawa Japan

Jingao Li China

Lin-Yong Zhao China

Sudhir Bahadur India

Jiaxi He China

V. Fanotto Italy

Li-Zhen Chen China

Kee Myung Lee South Korea

Doris M. Rassl United Kingdom

Yusuke Sato Japan

Yasutaka Sukawa Japan

Guoxiang Cai

645 ×0.9

ONCOL

234 ×0.6

SURGE

556 ×1.4

269 ×0.8

PRM

207 ×1.0

Citations per year, relative to Guoxiang Cai Guoxiang Cai (= 1×) peers Yasutaka Sukawa

Countries citing papers authored by Guoxiang Cai

Since Specialization

Citations

This map shows the geographic impact of Guoxiang Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoxiang Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoxiang Cai more than expected).

Fields of papers citing papers by Guoxiang Cai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guoxiang Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoxiang Cai. The network helps show where Guoxiang Cai may publish in the future.

Co-authorship network of co-authors of Guoxiang Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Guoxiang Cai. A scholar is included among the top collaborators of Guoxiang Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guoxiang Cai. Guoxiang Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Renjie, et al.. (2024). A comprehensive overview of the molecular features and therapeutic targets in BRAF^V600E‐mutant colorectal cancer. Clinical and Translational Medicine. 14(7). e1764–e1764. 3 indexed citations

Han, Lingyu, Weixing Dai, Wenqin Luo, et al.. (2023). Enhanced De Novo Lipid Synthesis Mediated by FASN Induces Chemoresistance in Colorectal Cancer. Cancers. 15(3). 562–562. 14 indexed citations

Dai, Weixing, Wenqiang Xiang, Lingyu Han, et al.. (2022). PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism. Cancer Communications. 42(9). 848–867. 69 indexed citations

Wei, Guoli, Liangjun Zhu, Lingjun Zhu, et al.. (2021). Preventive Efficacy and Safety of Yiqi-Wenjing-Fang Granules on Oxaliplatin-Induced Peripheral Neuropathy: A Protocol for a Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial. Evidence-based Complementary and Alternative Medicine. 2021. 1–9. 3 indexed citations

Han, Lingyu, Weixing Dai, Shaobo Mo, et al.. (2021). Nomogram of conditional survival probability of long-term Survival for Metastatic Colorectal Cancer: A Real-World Data Retrospective Cohort Study from SEER database. International Journal of Surgery. 92. 106013–106013. 24 indexed citations

Shen, Jie, Yi‐Ling Wu, Xiaoshuang Feng, et al.. (2021). Assessing Individual Risk for High-Risk Early Colorectal Neoplasm for Pre-Selection of Screening in Shanghai, China: A Population-Based Nested Case–Control Study. Cancer Management and Research. Volume 13. 3867–3878. 3 indexed citations

Zhang, Sheng, Cheng Kong, Yongzhi Yang, et al.. (2020). Human oral microbiome dysbiosis as a novel non-invasive biomarker in detection of colorectal cancer. Theranostics. 10(25). 11595–11606. 72 indexed citations

Wang, Renjie, Lingyu Han, Weixing Dai, et al.. (2020). Cause of death for elders with colorectal cancer: a real-world data analysis. Journal of Gastrointestinal Oncology. 11(2). 269–276. 12 indexed citations

Li, Menglei, Kai Sun, Weixing Dai, et al.. (2020). Preoperative prediction of peritoneal metastasis in colorectal cancer using a clinical-radiomics model. European Journal of Radiology. 132. 109326–109326. 16 indexed citations

10.

Zhang, S., Yongzhi Yang, Wenhao Weng, et al.. (2019). Fusobacterium nucleatum promotes chemoresistance to 5-fluorouracil by upregulation of BIRC3 expression in colorectal cancer. Journal of Experimental & Clinical Cancer Research. 38(1). 14–14. 237 indexed citations

11.

Dai, Weixing, Yaqi Li, Zhenyu Wu, et al.. (2019). Pathological nodal staging score for rectal cancer patients treated with radical surgery with or without neoadjuvant therapy: a postoperative decision tool. Cancer Management and Research. Volume 11. 537–546. 2 indexed citations

12.

Han, Lingyu, Shaobo Mo, Wenqiang Xiang, et al.. (2019). Prognostic accuracy of different lymph node staging system in predicting overall survival in stage IV colon cancer. International Journal of Colorectal Disease. 35(2). 317–322. 5 indexed citations

13.

Mo, Shaobo, Weixing Dai, Wenqiang Xiang, et al.. (2018). Survival Contradiction Between Stage IIA and Stage IIIA Rectal Cancer: A Retrospective Study. Journal of Cancer. 9(8). 1466–1475. 15 indexed citations

14.

Huang, Ben, et al.. (2016). Smaller tumor size is associated with poor survival in stage II colon cancer: An analysis of 7,719 patients in the SEER database. International Journal of Surgery. 33. 157–163. 31 indexed citations

15.

Huang, Ben, et al.. (2016). Log odds of positive lymph nodes is a superior prognostic indicator in stage III rectal cancer patients: A retrospective analysis of 17,632 patients in the SEER database. International Journal of Surgery. 32. 24–30. 31 indexed citations

16.

Xu, Ye, Qinghua Xu, Yang Li, et al.. (2013). Identification and Validation of a Blood-Based 18-Gene Expression Signature in Colorectal Cancer. Clinical Cancer Research. 19(11). 3039–3049. 18 indexed citations

17.

Peng, Junjie, et al.. (2010). Oncological outcome of T1 rectal cancer undergoing standard resection and local excision. Colorectal Disease. 13(2). e14–e19. 40 indexed citations

18.

Cai, Guoxiang, Ye Xu, Xiaoli Zhu, et al.. (2009). A Simple Scoring System Based on Clinical Features to Predict Locally Advanced Rectal Cancers. Journal of Gastrointestinal Surgery. 13(7). 1299–1305. 5 indexed citations

19.

Peng, Junjie, Ye Xu, Ji Zhu, et al.. (2008). Prognostic Significance of the Metastatic Lymph Node Ratio in Node-Positive Rectal Cancer. Annals of Surgical Oncology. 15(11). 3118–3123. 66 indexed citations

20.

Peng, Junjie, Jiade J. Lu, Ji Zhu, et al.. (2008). Prediction of Treatment Outcome by CD44v6 After Total Mesorectal Excision in Locally Advanced Rectal Cancer. The Cancer Journal. 14(1). 54–61. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact